Disclosed are pharmaceutical composition comprising a (a) PNP inhibitor and (b) an alkylating agent. Also disclosed is the use of the composition in the treatment of hematologic cancer and a kit comprising (a) PNP inhibitor and (b) an alkylating agent and/or an anti-CD20 agent. An example of an PNP inhibitor is forodesine.